Growth Metrics

Kraig Biocraft Laboratories (KBLB) Long-Term Debt Repayments (2019 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $20000.0 as the latest value for Q4 2022.

  • Quarterly Long-Term Debt Repayments rose 33.33% to $20000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $60000.0 through Dec 2022, up 20.0% year-over-year, with the annual reading at $125000.0 for FY2025, 254.67% up from the prior year.
  • Long-Term Debt Repayments hit $20000.0 in Q4 2022 for Kraig Biocraft Laboratories, down from $40000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $40000.0 in Q1 2022 to a low of $1000.0 in Q1 2019.
  • Historically, Long-Term Debt Repayments has averaged $15857.1 across 3 years, with a median of $15000.0 in 2021.
  • Biggest YoY gain for Long-Term Debt Repayments was 300.0% in 2022; the steepest drop was 33.33% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $1000.0 in 2019, then surged by 1400.0% to $15000.0 in 2021, then skyrocketed by 33.33% to $20000.0 in 2022.
  • Business Quant data shows Long-Term Debt Repayments for KBLB at $20000.0 in Q4 2022, $40000.0 in Q1 2022, and $15000.0 in Q4 2021.